Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-15T21:16:20.588Z Has data issue: false hasContentIssue false

Crystallographic study of PtCl2(C2H3O2)2(C6H13N)(NH3) by Rietveld refinement

Published online by Cambridge University Press:  06 March 2012

Lingmin Zeng*
Affiliation:
Institute of Materials Science, Guangxi University, Nanning, Guangxi 530004, People’s Republic of China
Liangwei Chen
Affiliation:
Sino-Platinum Metals Co. Ltd., Kunming 650221, People’s Republic of China
Shaoping Pu
Affiliation:
Institute of Precious Metals, Kunming 650221, People’s Republic of China
Yikun Yang
Affiliation:
Institute of Precious Metals, Kunming 650221, People’s Republic of China
Wenggui Gao
Affiliation:
Institute of Precious Metals, Kunming 650221, People’s Republic of China
Yao Yu
Affiliation:
Institute of Precious Metals, Kunming 650221, People’s Republic of China
*
a)Electronic mail: lmzeng@gxu.edu.cn
Get access

Abstract

X-ray powder diffraction data for the anticancer drug PtCl2(C2H3O2)2(C6H13N)(NH3) are reported. The crystal structure of PtCl2(C2H3O2)2(C6H13N)(NH3) obtained from a Rietveld refinement are: space group P21/a, a=13.547(2) Å, b=8.260(1) Å, c=14.638(3) Å, β=110.429(2)°, V=1534.96 Å3, Z=4 and Dcalc.=2.068 Mg/m3.

Information

Type
Technical Articles
Copyright
Copyright © Cambridge University Press 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable